- US12404343utility2025Humanised Anti Kallikrein-2 Antibody0 cites
- US12398209utility2025Methods of Treating Cancers with Antagonistic Anti-pd-1 Antibodies0 cites
- US12383637utility2025Therapeutic Agents and Uses Thereof0 cites
- USD1084307design2025Syringe Accessory0 cites
- US12304953utility2025Anti-cd3 Antibodies and Uses Thereof0 cites
- US12303483utility2025Lipase Degradation Resistant Surfactants for Use in Large Molecule Therapeutic Formulations0 cites
- US12304939utility2025EGFR and C-met Fibronectin Type III Domain Binding Molecules0 cites
- US12295997utility2025Prostate Neoantigens and Their Uses0 cites
- US12291566utility2025Anti-tnf Antibodies, Compositions, and Methods for the Treatment of Active Ankylosing Spondylitis0 cites
- US12291797utility2025Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses0 cites
- US12286474utility2025Anti-cd38 Antibodies for Treatment of Acute Myeloid Leukemia0 cites
- US12275766utility2025Neoantigen Peptide Mimics0 cites
- US12269870utility2025Antigen Binding Regions Against Fibronectin Type III Domains and Methods of Using the Same0 cites
- US12264197utility2025Anti-vβ17/anti-cd123 Bispecific Antibodies0 cites
- US12258328utility20256-membered Heteroaryl-containing Aminopyridine Compounds as EGFR Inhibitors0 cites
- US12258327utility20255-membered Heteroaryl-containing Aminopyridine Compounds as EGFR Inhibitors0 cites
- US12258385utility2025CD137 Binding Fibronectin Type III Domains0 cites
- US12258393utility2025Method of Treating Inflammatory Bowel Disease with a Combination Therapy of Antibodies to IL-23 and TNF Alpha0 cites
- US12247077utility2025Bispecific Egfr/c-met Antibodies0 cites
- US12240790utility2025Radiolabeling of Polypeptides0 cites